Obesity is central to development of MetDys, which originates with obesity-induced adipose tissue dysfunction, resulting in altered serum levels of adipocytes leptin and adiponectin and induction of chronic systemic inflammation [3]. Here, ADIPOQ is linked to obesity due to melanocortin 4 receptor deficiency.